Your browser doesn't support javascript.
loading
Clinical utility of target capture-based panel sequencing in hematological malignancies: A multicenter feasibility study.
Yasuda, Takahiko; Sanada, Masashi; Nishijima, Dai; Kanamori, Takashi; Iijima, Yuka; Hattori, Hiroyoshi; Saito, Akiko; Miyoshi, Hiroaki; Ishikawa, Yuichi; Asou, Norio; Usuki, Kensuke; Hirabayashi, Shinsuke; Kato, Motohiro; Ri, Masaki; Handa, Hiroshi; Ishida, Tadao; Shibayama, Hirohiko; Abe, Masahiro; Iriyama, Chisako; Karube, Kennosuke; Nishikori, Momoko; Ohshima, Koichi; Kataoka, Keisuke; Yoshida, Kenichi; Shiraishi, Yuichi; Goto, Hiroaki; Adachi, Souichi; Kobayashi, Ryoji; Kiyoi, Hitoshi; Miyazaki, Yasushi; Ogawa, Seishi; Kurahashi, Hiroki; Yokoyama, Hisayuki; Manabe, Atsushi; Iida, Shinsuke; Tomita, Akihiro; Horibe, Keizo.
  • Yasuda T; Clinical Research Center, National Hospital Organization Nagoya Medical Center, Nagoya, Japan.
  • Sanada M; Clinical Research Center, National Hospital Organization Nagoya Medical Center, Nagoya, Japan.
  • Nishijima D; Clinical Research Center, National Hospital Organization Nagoya Medical Center, Nagoya, Japan.
  • Kanamori T; Clinical Research Center, National Hospital Organization Nagoya Medical Center, Nagoya, Japan.
  • Iijima Y; Department of Hematology and Oncology, Nagoya City University Institute of Medical and Pharmaceutical Science, Nagoya, Japan.
  • Hattori H; Clinical Research Center, National Hospital Organization Nagoya Medical Center, Nagoya, Japan.
  • Saito A; Clinical Research Center, National Hospital Organization Nagoya Medical Center, Nagoya, Japan.
  • Miyoshi H; Clinical Research Center, National Hospital Organization Nagoya Medical Center, Nagoya, Japan.
  • Ishikawa Y; Department of Pathology, Kurume University School of Medicine, Kurume, Japan.
  • Asou N; Department of Hematology and Oncology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
  • Usuki K; Department of Hematology, Comprehensive Cancer Center, International Medical Center, Saitama Medical University, Saitama, Japan.
  • Hirabayashi S; Department of Hematology, NTT Medical Center Tokyo, Tokyo, Japan.
  • Kato M; Department of Pediatrics, Hokkaido University Graduate School of Medicine, Sapporo, Japan.
  • Ri M; Department of Pediatric Hematology and Oncology Research, National Research Institute for Child Health and Development, Tokyo, Japan.
  • Handa H; Department of Hematology and Oncology, Nagoya City University Institute of Medical and Pharmaceutical Science, Nagoya, Japan.
  • Ishida T; Department of Hematology, Gunma University Graduate School of Medicine, Maebashi, Japan.
  • Shibayama H; Department of Hematology, Japanese Red Cross Medical Center, Tokyo, Japan.
  • Abe M; Department of Hematology and Oncology, Osaka University Graduate School of Medicine, Osaka, Japan.
  • Iriyama C; Department of Hematology, Endocrinology and Metabolism, Tokushima University Graduate School, Tokushima, Japan.
  • Karube K; Department of Hematology, Fujita Health University, Toyoake, Japan.
  • Nishikori M; Department of Pathology and Cell Biology, Graduate School of Medicine and Faculty of Medicine, University of the Ryukyus, Okinawa, Japan.
  • Ohshima K; Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
  • Kataoka K; Department of Pathology, Kurume University School of Medicine, Kurume, Japan.
  • Yoshida K; Division of Molecular Oncology, National Cancer Center Research Institute, Tokyo, Japan.
  • Shiraishi Y; Department of Pathology and Tumor biology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
  • Goto H; Division of Cellular Signaling, National Cancer Center Research Institute, Tokyo, Japan.
  • Adachi S; Division of Hemato-Oncology and Regenerative Medicine, Kanagawa Children's Medical Center, Yokohama, Japan.
  • Kobayashi R; Department of Human Health Science, Kyoto University, Kyoto, Japan.
  • Kiyoi H; Department of Pediatrics, Sapporo Hokuyu Hospital, Sapporo, Japan.
  • Miyazaki Y; Department of Hematology and Oncology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
  • Ogawa S; Department of Hematology, Atomic Bomb Disease and Hibakusha Medicine Unit, Atomic Bomb Disease Institute, Nagasaki University, Nagasaki, Japan.
  • Kurahashi H; Department of Pathology and Tumor biology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
  • Yokoyama H; Institute for the Advanced Study of Human Biology (WPI-ASHBi), Kyoto, Japan.
  • Manabe A; Department of Medicine, Center for Hematology and Regenerative Medicine, Karolinska Institute, Stockholm, Sweden.
  • Iida S; Division of Molecular Genetics, Institute for Comprehensive Medical Science, Fujita Health University, Toyoake, Japan.
  • Tomita A; Department of Hematology, National Hospital Organization, Sendai Medical Center, Sendai, Japan.
  • Horibe K; Department of Pediatrics, Hokkaido University Graduate School of Medicine, Sapporo, Japan.
Cancer Sci ; 111(9): 3367-3378, 2020 Sep.
Article en En | MEDLINE | ID: mdl-32619037
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Biomarcadores de Tumor / Neoplasias Hematológicas / Predisposición Genética a la Enfermedad / Estudios de Asociación Genética Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Adolescent / Adult / Aged / Aged80 / Child / Child, preschool / Female / Humans / Infant / Male Idioma: En Año: 2020 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Biomarcadores de Tumor / Neoplasias Hematológicas / Predisposición Genética a la Enfermedad / Estudios de Asociación Genética Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Adolescent / Adult / Aged / Aged80 / Child / Child, preschool / Female / Humans / Infant / Male Idioma: En Año: 2020 Tipo del documento: Article